Australia's Radiopharm Theranostics rises on supply agreement with Dutch firm

Radiopharm Theranostics

17/04/2023 06:30

** Shares of Radiopharm Theranostics Ltd  RAD.AX  rise as
much as 5.9% to A$0.180, their highest level since Sept. 16,
2022 
    ** Radiopharmaceutical product maker says it has entered
into supply agreement with TerThera to supply the co with
Terbium-161(Tb-161) isotope
    ** TerThera is a radionuclide production-focussed co based
in the Netherlands
    ** Terbium-161 is a highly promising isotope for targeted
cancer treatment due to its unique characteristics of radiation
emitted
    ** RAD says supply agreement is for an initial period of
three years and may be extended for additional two years
    ** More than 417,000 shares change hands, vs the 30-day
average volume of 238,000 shares
    ** Stock has risen 61.9% this year, as of last close
    
  

 (Reporting by Udbhav Krishna P in Bengaluru)
 ((UdbhavKrishna.P@thomsonreuters.com))